Oxidative folding: Coupling conformational folding and disulfide formation

Protein Reviews

Volumn 14, Issue , 2011, Pages 1-22

  Ventura, Salvador ^a   Chang, Rowen J Y ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE

Author keywords

Disulfide bonds; Folding intermediates; Folding pathways; Oxidative folding; Protein folding; Protein structure; Reductive unfolding

Indexed keywords

DISULFIDE; EPIDERMAL GROWTH FACTOR; HIRUDIN; PROTEIN; TRYPSIN INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; SEPARATION TECHNIQUE; THERMODYNAMICS;

EID: 83455176984     PISSN: 18713025     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7273-6_1     Document Type: Article

References (86)

1. Abkevich VI, Shakhnovich EI.2000) What can disulfide bonds tell us about protein energetics function and folding: Simulations and bioinformatics analysis. J Mol Biol 300:975-985
2. Anfinsen CB.1972) The formation and stabilization of protein structure. Biochem J 128:737-749
3. Arias-Moreno X, Arolas JL, Aviles FX, Sancho J, Ventura S.2008) Scrambled isomers as key intermediates in the oxidative folding of ligand binding module 5 of the low density lipoprotein receptor. J Biol Chem 283:13627-13637
4. Arolas JL, Bronsoms S, Lorenzo J, Aviles FX, Chang JY, Ventura S.2004) Role of kinetic intermediates in the folding of leech carboxypeptidase inhibitor. J Biol Chem 279:37261-37270 (Pubitemid 39195432)
5. Arolas JL, D'silva L, Popowicz GM, Aviles FX, Holak TA, Ventura S.2005) NMR structural characterization and computational predictions of the major intermediate in oxidative folding of leech carboxypeptidase inhibitor. Structure 13:1193-1202 (Pubitemid 41111486)
6. Arolas JL, Aviles FX, Chang JY, Ventura S.2006) Folding of small disulfide-rich proteins: Clarifying the puzzle. Trends Biochem Sci 31:292-301 (Pubitemid 43674360)
7. Arolas JL, Bronsoms S, Aviles FX, Ventura S, Sommerhoff CP.2008a) Oxidative folding of leechderived tryptase inhibitor via native disulfide-bonded intermediates. Antioxid Redox Signal 10:77-85 (Pubitemid 350115987)
8. Arolas JL, Pantoja-Uceda D, Ventura S, Blanco FJ, Aviles FX.2008b) The NMR structures of the major intermediates of the two-domain tick carboxypeptidase inhibitor reveal symmetry in its folding and unfolding pathways. J Biol Chem 283:27110-27120
9. Arolas JL, Castillo V, Bronsoms S, Aviles FX, Ventura S.2009) Designing out disulfide bonds of leech carboxypeptidase inhibitor: Implications for its folding, stability and function. J Mol Biol 392:529-546
10. Auerswald EA, Morenweiser R, Sommerhoff CP, Piechottka GP, Eckerskorn C, Gurtler LG, Fritz H.1994) Recombinant leech-derived tryptase inhibitor: Construction, production, protein chemical characterization and inhibition of HIV-1 replication. Biol Chem Hoppe Seyler 375:695-703
11. Baldwin RL.1994) Finding intermediates in protein folding. Bioessays 16:207-210
12. Bryngelson JD, Onuchic JN, Socci ND, Wolynes PG.1995) Funnels, pathways, and the energy landscape of protein folding: A synthesis. Proteins 21:167-195
13. Camacho CJ, Thirumalai D.1995) Modeling the role of disulfide bonds in protein folding: entropic barriers and pathways. Proteins 22:27-40
14. Cemazar M, Joshi A, Daly NL, Mark AE, Craik DJ.2008) The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein. Structure 16:842-851 (Pubitemid 351778379)
15. Chang J.Y.1983) The functional domain of hirudin, a thrombin-specific inhibitor. FEBS Lett 164:307-313 (Pubitemid 14177141)
16. Chang J.Y.1994) Controlling the speed of hirudin folding. Biochem J 300:643-650
17. Chang J.Y.1996) The disulfide folding pathway of tick anticoagulant peptide.TAP), a Kunitz-type inhibitor structurally homologous to BPTI. Biochemistry 35:11702-11709
18. Chang J.Y.2004) Evidence for the underlying cause of diversity of the disulfide folding pathway. Biochemistry 43:4522-4529
19. Chang J.Y.2008) Diversity of folding pathways and folding models of disulfide proteins. Antioxid Redox Signal 10:171-177
20. Chang JY, Li L.2005) Divergent folding pathways of two homologous proteins, BPTI and tick anticoagulant peptide: Compartmentalization of folding intermediates and identification of kinetic traps. Arch Biochem Biophys 437:85-95 (Pubitemid 40463684)
21. Chang JY, Schindler P, Chatrenet B.1995) The disulfide structures of scrambled hirudins. J Biol Chem 270:11992-11997
22. Chang JY, Li L, Lai PH.2001) A major kinetic trap for the oxidative folding of human epidermal growth factor. J Biol Chem 276:4845-4852
23. Chatrenet B, Chang J.Y.1992) The folding of hirudin adopts a mechanism of trial and error. J Biol Chem 267:3038-3043
24. Chatrenet B, Chang J.Y.1993) The disulfide folding pathway of hirudin elucidated by stop/go folding experiments. J Biol Chem 268:20988-20996 (Pubitemid 23292280)
25. Creighton T.E.1974) Renaturation of the reduced bovine pancreatic trypsin inhibitor. J Mol Biol 87:563-577
26. Creighton T.E.1979) Electrophoretic analysis of the unfolding of proteins by urea. J Mol Biol 129:235-264
27. Creighton T.E.1986) Disulfide bonds as probes of protein folding pathways. Methods Enzymol 131:83-106 (Pubitemid 16002197)
28. Creighton T.E.1988a) The protein folding problem. Science 240(267):344
29. Creighton T.E.1988b) Toward a better understanding of protein folding pathways. Proc Natl Acad Sci USA 85:5082-5086
30. Creighton T.E.1990) Protein folding. Biochem J 270:1-16 (Pubitemid 20275568)
31. Creighton T.E.1997) Protein folding coupled to disulphide bond formation. Biol Chem 378:731-744 (Pubitemid 27388932)
32. Creighton TE, Goldenberg D.P.1984) Kinetic role of a meta-stable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor. J Mol Biol 179:497-526 (Pubitemid 16223357)
33. Dadlez M.1997) Hydrophobic interactions accelerate early stages of the folding of BPTI. Biochemistry 36:2788-2797 (Pubitemid 27138560)
34. Daggett V, Fersht A.2003) The present view of the mechanism of protein folding. Nat Rev Mol Cell Biol 4:497-502 (Pubitemid 36648595)
35. Darby NJ, Creighton T.E.1993) Dissecting the disulphide-coupled folding pathway of bovine pancreatic trypsin inhibitor. Forming the first disulphide bonds in analogues of the reduced protein. J Mol Biol 232:873-896 (Pubitemid 23256980)
36. Darby N, Creighton T.E.1997) Probing protein folding and stability using disulfide bonds. Mol Biotechnol 7:57-77 (Pubitemid 127499081)
37. Di Marco S, Priestle J.P.1997) Structure of the complex of leech-derived tryptase inhibitor.LDTI) with trypsin and modeling of the LDTI-tryptase system. Structure 5:1465-1474 (Pubitemid 27521802)
38. Dill KA, Ozkan SB, Weikl TR, Chodera JD, Voelz VA.2007) The protein folding problem: When will it be solved? Curr Opin Struct Biol 17:342-346 (Pubitemid 47021366)
39. Dobson CM, EVans P.A.1988) Protein structure. Trapping folding intermediates. Nature 335:666-667
40. Eisenberg D, Marcotte EM, Xenarios I, Yeates TO.2000) Protein function in the post-genomic era. Nature 405:823-826
41. Fetrow JS, Giammona A, Kolinski A, Skolnick J.2002) The protein folding problem: A biophysical enigma. Curr Pharm Biotechnol 3:329-347 (Pubitemid 35364008)
42. Folkers PJ, Clore GM, Driscoll PC, Dodt J, Kohler S, Gronenborn A.M.1989) Solution structure of recombinant hirudin and the Lys-47-Glu mutant: A nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. Biochemistry 28:2601-2617 (Pubitemid 19094380)
43. Gruebele M.1999) The fast protein folding problem. Annu Rev Phys Chem 50:485-516 (Pubitemid 129565557)
44. Grutter MG, Priestle JP, Rahuel J, Grossenbacher H, Bode W, Hofsteenge J, Stone S.R.1990 Crystal structure of the thrombin-hirudin complex: A novel mode of serine protease inhibition. EMBO J 9:2361-2365
45. Guerois R, Serrano L.2000) The SH3-fold family: experimental evidence and prediction of variations in the folding pathways. J Mol Biol 304:967-982 (Pubitemid 32047094)
46. Hogg PJ.2003) Disulfide bonds as switches for protein function. Trends Biochem Sci 28:210-214 (Pubitemid 36507160)
47. Hogg PJ.2009) Contribution of allosteric disulfide bonds to regulation of hemostasis. J Thromb Haemost 7(Suppl 1):13-16
48. Honig B, Ray A, Levinthal C.1976) Conformational flexibility and protein folding: Rigid structural fragments connected by flexible joints in subtilisin BPN. Proc Natl Acad Sci USA 73:1974-1978
49. Karplus M, Weaver DL.1994) Protein folding dynamics: The diffusion-collision model and experimental data. Protein Sci 3:650-668 (Pubitemid 24136370)
50. Kibria FM, Lees W.J.2008) Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor.BPTI) with glutathione and glutathione disulfide. J Am Chem Soc 130:796-797
51. Kim PS, Baldwin RL.1982) Specific intermediates in the folding reactions of small proteins and the mechanism of protein folding. Annu Rev Biochem 51:459-489
52. Kortemme T, Hollecker M, Kemmink J, Creighton T.E.1996) Comparison of the.30-51, 14-38) two-disulphide folding intermediates of the homologous proteins dendrotoxin K and bovine pancreatic trypsin inhibitor by two-dimensional 1H nuclear magnetic resonance. J Mol Biol 257:188-198
53. Laity JH, Lester CC, Shimotakahara S, Zimmerman DE, Montelione GT, Scheraga H.A.1997 Structural characterization of an analog of the major rate-determining disulfide folding intermediate of bovine pancreatic ribonuclease A. Biochemistry 36:12683-12699 (Pubitemid 27465378)
54. Mamathambika BS, Bardwell J.C.2008) Disulfide-linked protein folding pathways. Annu Rev Cell Dev Biol 24:211-235
55. Margittai E, Csala M, Mandl J, Banhegyi G.2009) Participation of low molecular weight electron carriers in oxidative protein folding. Int J Mol Sci 10:1346-1359
56. Montelione GT, Wuthrich K, Burgess AW, Nice EC, Wagner G, Gibson KD, Scheraga H.A.1992 Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints. Biochemistry 31:236-249
57. Muhlhahn P, Czisch M, Morenweiser R, Habermann B, Engh RA, Sommerhoff CP, Auerswald EA, Holak TA.1994) Structure of leech derived tryptase inhibitor.LDTI-C) in solution. FEBS Lett 355:290-296 (Pubitemid 24359925)
58. Narayan M, Welker E, Wedemeyer WJ, Scheraga H.A.2000) Oxidative folding of proteins. Acc Chem Res 33:805-812
59. Narayan M, Welker E, Scheraga H.A.2003a) Native conformational tendencies in unfolded polypeptides: Development of a novel method to assess native conformational tendencies in the reduced forms of multiple disulfide-bonded proteins. J Am Chem Soc 125:2036-2037 (Pubitemid 36245683)
60. Narayan M, Welker E, Wanjalla C, Xu G, Scheraga H.A.2003b) Shifting the competition between the intramolecular reshuffling reaction and the direct oxidation reaction during the oxidative folding of kinetically trapped disulfide-insecure intermediates. Biochemistry 42:10783-10789 (Pubitemid 37102118)
61. Nishimura C, Lietzow MA, Dyson HJ, Wright PE.2005) Sequence determinants of a protein folding pathway. J Mol Biol 351:383-392 (Pubitemid 41007756)
62. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S.2002) Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775-787 (Pubitemid 35291060)
63. Pantoja-Uceda D, Arolas JL, Aviles FX, Santoro J, Ventura S, Sommerhoff CP.2009) Deciphering the structural basis that guides the oxidative folding of leech-derived tryptase inhibitor. J Biol Chem 284:35612-35620
64. Plaxco KW, Simons KT, Baker D.1998) Contact order, transition state placement and the refolding rates of single domain proteins. J Mol Biol 277:985-994 (Pubitemid 28195995)
65. Poland DC, Scheraga H.A.1965) Comparison of theories of the helix-coil transition in polypeptides. J Chem Phys 43:2071-2074
66. Ptitsyn OB.1991) How does protein synthesis give rise to the 3D-structure? FEBS Lett 285:176-181
67. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton JW II.1990) The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 249:277-280
68. Saaranen MJ, Karala AR, Lappi AK, Ruddock LW.2010) The role of dehydroascorbate in disulfide bond formation. Antioxid Redox Signal 12:15-25
69. Sanchez R, Pieper U, Melo F, Eswar N, Marti-Renom MA, Madhusudhan MS, Mirkovic N, Sali A.2000) Protein structure modeling for structural genomics. Nat Struct Biol 7(Suppl):986-990
70. Scheraga HA, Konishi Y, Rothwarf DM, Mui PW.1987) Toward an understanding of the folding of ribonuclease A. Proc Natl Acad Sci USA 84:5740-5744
71. Shimotakahara S, Rios CB, Laity JH, Zimmerman DE, Scheraga HA, Montelione GT.1997) NMR structural analysis of an analog of an intermediate formed in the rate-determining step of one pathway in the oxidative folding of bovine pancreatic ribonuclease A: Automated analysis of 1H, 13C, and 15N resonance assignments for wild-type and [C65S, C72S] mutant forms. Biochemistry 36:6915-6929 (Pubitemid 27258102)
72. Sommerhoff CP, Sollner C, Mentele R, Piechottka GP, Auerswald EA, Fritz H.1994) A Kazaltype inhibitor of human mast cell tryptase: Isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. Biol Chem Hoppe Seyler 375:685-694
73. Stubbs MT, Morenweiser R, Sturzebecher J, Bauer M, Bode W, Huber R, Piechottka GP, Matschiner G, Sommerhoff CP, Fritz H, Auerswald E.A.1997) The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition. J Biol Chem 272:19931-19937 (Pubitemid 27340093)
74. Ventura S.2008) Oxidative protein folding: From the test tube to in vivo insights. Antioxid Redox Signal 10:51-53 (Pubitemid 350115994)
75. Wedemeyer WJ, Welker E, Narayan M, Scheraga H.A.2000a) Disulfide bonds and protein folding. Biochemistry 39:7032
76. Wedemeyer WJ, Welker E, Narayan M, Scheraga H.A.2000b) Disulfide bonds and protein folding. Biochemistry 39:4207-4216 (Pubitemid 30212634)
77. Wedemeyer WJ, Xu X, Welker E, Scheraga H.A.2002) Conformational propensities of protein folding intermediates: Distribution of species in the 1S, 2S, and 3S ensembles of the [C40A, C95A] mutant of bovine pancreatic ribonuclease A. Biochemistry 41:1483-1491 (Pubitemid 34112737)
78. Weissman J.S.1995) All roads lead to Rome? The multiple pathways of protein folding. Chem Biol 2:255-260
79. Weissman JS, Kim PS.1991) Reexamination of the folding of BPTI: Predominance of native intermediates. Science 253:1386-1393 (Pubitemid 21917286)
80. Weissman JS, Kim PS.1992) Kinetic role of nonnative species in the folding of bovine pancreatic trypsin inhibitor. Proc Natl Acad Sci USA 89:9900-9904
81. Welker E, Narayan M, Wedemeyer WJ, Scheraga H.A.2001a) Structural determinants of oxidative folding in proteins. Proc Natl Acad Sci 98:2312-2316 (Pubitemid 32209479)
82. Welker E, Wedemeyer WJ, Narayan M, Scheraga H.A.2001b) Coupling of conformational folding and disulfide-bond reactions in oxidative folding of proteins. Biochemistry 40:9059-9064 (Pubitemid 32730026)
83. Welker E, Hathaway L, Scheraga H.A.2004) A new method for rapid characterization of the folding pathways of multidisulfide-containing proteins. J Am Chem Soc 126:3720-3721 (Pubitemid 38391858)
84. Wouters MA, Fan SW, Haworth NL.2010) Disulfides as redox switches: From molecular mechanisms to functional significance. Antioxid Redox Signal 12:53-91
85. Wu J, Yang Y, Watson JT.1998) Trapping of intermediates during the refolding of recombinant human epidermal growth factor.hEGF) by cyanylation, and subsequent structural elucidation by mass spectrometry. Protein Sci 7:1017-1028 (Pubitemid 28216543)
86. Zavodszky M, Chen CW, Huang JK, Zolkiewski M, Wen L, Krishnamoorthi R.2001) Disulfide bond effects on protein stability: Designed variants of Cucurbita maxima trypsin inhibitor-V. Protein Sci 10:149-160 (Pubitemid 32221173)